National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National HealthCare Corporation declared a quarterly cash dividend of $0.67 per common share, payable on October 30, 2026 to shareholders of record as of September 30, 2026. The company communicated this action through a press release referenced in the current report.
As of August 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,323 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 775 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies, along with additional post-acute and support services. The release includes customary forward-looking statement cautions referencing regulatory, operational, and reimbursement risks.
National HealthCare Corporation reported stronger results for the quarter ended June 30, 2026. Net operating revenues were $408,025,000 compared with $374,910,000 a year earlier, an 8.8% increase, driven primarily by the June 1, 2026 acquisition of five skilled nursing facilities with 639 licensed beds in Tennessee and South Carolina.
GAAP net income attributable to NHC was $40,319,000 versus $23,722,000 in the prior-year quarter, with GAAP diluted EPS of $2.54 versus $1.52. Excluding unrealized gains on marketable equity securities and other non-GAAP adjustments, adjusted net income was $27,551,000 versus $25,710,000, a 7.2% increase, and adjusted diluted EPS was $1.74 versus $1.65. For the first six months of 2026, net operating revenues totaled $789,846,000 and GAAP diluted EPS was $4.82.
On the balance sheet as of June 30, 2026, total assets were $1,536,930,000, NHC stockholders’ equity was $1,122,302,000, and current and long-term debt was eliminated compared with $40,000,000 at December 31, 2025. The quarterly dividend declared per common share was $0.67, up from $0.64 a year earlier.
National HealthCare Corporation delivered stronger Q2 2026 results, with net operating revenues of $408,025 (in thousands) and net income attributable to the company of $40,319 (in thousands), compared with $374,910 and $23,722 (in thousands) a year earlier. Diluted EPS rose to $2.54 from $1.52, helped by higher net patient revenues and a jump in other revenues to $29,666 (in thousands), including $18,325 (in thousands) of previously constrained management fees recognized after a related acquisition. Operating cash flow for the first six months was $105,802 (in thousands).
Balance sheet liquidity was supported by $52,278 (in thousands) of cash and restricted cash at June 30, 2026 and no long-term debt outstanding, while a new unsecured credit agreement for a $475,000,000 term loan and a $75,000,000 revolver became effective July 1 to finance real estate purchases. The company bought five skilled nursing facilities on June 1 for $50,500,000 and, subsequent to quarter-end, agreed to acquire 32 skilled nursing and three independent living facilities from National Health Investors for $560,000,000, funded by $475,000,000 of term loans and $55,000,000 drawn on the new revolver. NHC also returned capital via $23,561,000 of share repurchases and dividends of $0.64 and $0.67 per share in the first two quarters, while maintaining skilled nursing occupancy around 90% and accrued risk reserves of $121,129,000.
National HealthCare Corporation reports that First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly reported beneficial ownership of 795,771 shares of National HealthCare common stock, representing 5.09% of the class as of June 30, 2026.
The reporting persons show no sole voting or dispositive power, with shared voting power over 780,661 shares and shared dispositive power over 795,771 shares. The holdings are primarily in unit investment trusts and other investment vehicles for which First Trust entities act as sponsor or advisor. Voting of the unit investment trust shares is carried out by the trustee, and the reporting entities disclaim beneficial ownership of the reported shares.
National HealthCare Corporation completed a major real estate transaction by acquiring from National Health Investors the land and buildings for 32 skilled nursing facilities and three independent living facilities it had long leased, for a $560 million cash purchase price.
The company funded the deal with borrowings under its new Credit Agreement, drawing $475 million from a senior unsecured term loan and $55 million from its senior unsecured revolving credit facility, plus cash on hand. It simultaneously increased the revolver capacity from $50 million to $75 million and terminated commitments under a prior 2024 credit facility that had no outstanding borrowings.
A Partial Master Lease Termination Agreement ended the master lease for all acquired facilities except four Florida skilled nursing facilities, where a third-party operator’s lease continues and the master lease for those properties was assigned to an NHC subsidiary. NHC states that owning these properties, located across seven states, aligns with its strategy and is expected to be accretive to earnings, cash flow, and long-term investor returns.
National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.
The director also holds multiple stock option grants, each covering 7,500 underlying common shares, with exercise prices ranging from $55.75 to $171.42 and expiration dates from 2027 through 2031. These options represent ongoing equity-based compensation rather than new purchases or sales.
National Healthcare Corp’s SVP and CFO, Brian F. Kidd, reported a Form 4 showing a bona fide gift of 500 shares of common stock at $0.00 per share, leaving him with 29,996 common shares held directly.
The filing also details his outstanding stock options on common stock, including 14,000 underlying shares at $157.13 expiring on February 23, 2031, 9,000 shares at $90.62 expiring on February 24, 2030, 4,000 shares at $94.10 expiring on March 5, 2029, and 4,147 shares at $53.94 expiring on March 8, 2028.
NATIONAL HEALTHCARE CORP director Emil E. Hassan reported an open-market sale of 1,563 shares of common stock at $199.975 per share. After this transaction, he directly holds 71,532 shares. He also retains several stock option awards, each covering 7,500 underlying shares from 2022–2026 grants with exercise prices between $55.75 and $171.42 and expirations from 2027 to 2031.
National Healthcare Corp director Robert G. Adams reported routine equity movements involving company stock and options. On 2026-06-08, a trust for which he serves as trustee exercised options to acquire 4,000 shares of common stock at $69.19 per share, and that same trust made a bona fide gift of 4,000 shares at no stated price.
Separate entries list his indirect partnership holdings of 430,341 shares and show that, after these transactions, the trust holds 13,579 shares. He also continues to hold multiple stock option grants directly, each covering 7,500 underlying shares with exercise prices between $55.75 and $171.42 and expirations from 2028 to 2031. The filing reflects exercises, gifts, and existing holdings rather than open-market buying or selling.
NATIONAL HEALTHCARE CORP director Lisa Piercey reported an open‑market purchase of 949 shares of Common Stock at $184.2559 per share. Following this transaction, she holds 949 Common shares directly. The filing also lists a 2026 stock option grant covering 7,500 underlying Common shares at a $171.42 exercise price, expiring on May 6, 2031, with a corrected expiration date noted for this option award.